Published in J Physiol Biochem on March 28, 2015
Physiology and role of irisin in glucose homeostasis. Nat Rev Endocrinol (2017) 0.82
Elevated circulating irisin is associated with lower risk of insulin resistance: association and path analyses of obese Chinese adults. BMC Endocr Disord (2016) 0.76
Effects of Body Weight Reduction on Serum Irisin and Metabolic Parameters in Obese Subjects. Diabetes Metab J (2016) 0.75
Effects of physical activity on the link between PGC-1a and FNDC5 in muscle, circulating Ιrisin and UCP1 of white adipocytes in humans: A systematic review. F1000Res (2017) 0.75
The human obesity gene map: the 2005 update. Obesity (Silver Spring) (2006) 7.17
Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner. Cell Metab (2010) 4.08
Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance. Endocrinology (2004) 3.50
Identification of IRS-1 Ser-1101 as a target of S6K1 in nutrient- and obesity-induced insulin resistance. Proc Natl Acad Sci U S A (2007) 3.32
Short sleep duration is associated with reduced leptin levels and increased adiposity: Results from the Quebec family study. Obesity (Silver Spring) (2007) 3.23
Chronic rapamycin treatment causes glucose intolerance and hyperlipidemia by upregulating hepatic gluconeogenesis and impairing lipid deposition in adipose tissue. Diabetes (2010) 2.65
Overactivation of S6 kinase 1 as a cause of human insulin resistance during increased amino acid availability. Diabetes (2005) 2.55
Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men: 13-year follow-up data from the Québec Cardiovascular Study. Arterioscler Thromb Vasc Biol (2004) 2.50
The association between sleep duration and weight gain in adults: a 6-year prospective study from the Quebec Family Study. Sleep (2008) 2.30
Effects of experimental weight perturbation on skeletal muscle work efficiency in human subjects. Am J Physiol Regul Integr Comp Physiol (2003) 2.28
Obesity as a disease: a white paper on evidence and arguments commissioned by the Council of the Obesity Society. Obesity (Silver Spring) (2008) 2.23
The effect of obesity on chronic respiratory diseases: pathophysiology and therapeutic strategies. CMAJ (2006) 2.20
Role of dietary proteins and amino acids in the pathogenesis of insulin resistance. Annu Rev Nutr (2007) 2.03
Muscle atrophy and hypertrophy signaling in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2007) 2.01
Effects of exercise training on glucose homeostasis: the HERITAGE Family Study. Diabetes Care (2005) 1.96
Video game playing increases food intake in adolescents: a randomized crossover study. Am J Clin Nutr (2011) 1.92
Insulin resistance syndrome, body mass index and the risk of ischemic heart disease. CMAJ (2005) 1.86
Impact of waist circumference on the relationship between blood pressure and insulin: the Quebec Health Survey. Hypertension (2005) 1.83
Body weight is a strong predictor of postural stability. Gait Posture (2006) 1.76
Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes. Endocrinology (2004) 1.71
Adiponectin and adiponectin receptor gene variants in relation to resting metabolic rate, respiratory quotient, and adiposity-related phenotypes in the Quebec Family Study. Am J Clin Nutr (2007) 1.65
The human obesity gene map: the 2004 update. Obes Res (2005) 1.64
Aging per se does not influence glucose homeostasis: in vivo and in vitro evidence. Diabetes Care (2003) 1.62
Supplementation with calcium + vitamin D enhances the beneficial effect of weight loss on plasma lipid and lipoprotein concentrations. Am J Clin Nutr (2007) 1.61
Calcium plus vitamin D supplementation and fat mass loss in female very low-calcium consumers: potential link with a calcium-specific appetite control. Br J Nutr (2009) 1.60
Visceral obesity and the heart. Int J Biochem Cell Biol (2007) 1.58
Cardioprotective effects of glucose and insulin administration while maintaining normoglycemia (GIN therapy) in patients undergoing coronary artery bypass grafting. J Clin Endocrinol Metab (2011) 1.57
Sex differences in inflammatory markers: what is the contribution of visceral adiposity? Am J Clin Nutr (2009) 1.51
Sleep duration as a risk factor for the development of type 2 diabetes or impaired glucose tolerance: analyses of the Quebec Family Study. Sleep Med (2009) 1.49
Evidence for impaired lipolysis in abdominally obese men: postprandial study of apolipoprotein B-48- and B-100-containing lipoproteins. Am J Clin Nutr (2002) 1.49
Plasminogen-activator inhibitor-1 polymorphisms are associated with obesity and fat distribution in the Quebec Family Study: evidence of interactions with menopause. Menopause (2005) 1.43
Effects of intense and prolonged exercise on insulin sensitivity and glycogen metabolism in hypertensive subjects. Circulation (2003) 1.42
The SHP-1 protein tyrosine phosphatase negatively modulates glucose homeostasis. Nat Med (2006) 1.42
Eating behaviors and indexes of body composition in men and women from the Québec family study. Obes Res (2003) 1.41
Calcium intake, body composition, and lipoprotein-lipid concentrations in adults. Am J Clin Nutr (2003) 1.40
Impact of brisk walking on perceived health evaluated by a novel short questionnaire in sedentary and moderately obese postmenopausal women. Menopause (2013) 1.39
Visceral obesity and plasma glucose-insulin homeostasis: contributions of interleukin-6 and tumor necrosis factor-alpha in men. J Clin Endocrinol Metab (2008) 1.39
Exercise-induced hypertension in men with metabolic syndrome: anthropometric, metabolic, and hemodynamic features. Metab Syndr Relat Disord (2012) 1.39
Inhibition of inducible nitric-oxide synthase by activators of AMP-activated protein kinase: a new mechanism of action of insulin-sensitizing drugs. J Biol Chem (2004) 1.38
The human obesity gene map: the 2003 update. Obes Res (2004) 1.36
Adiponectinemia in visceral obesity: impact on glucose tolerance and plasma lipoprotein and lipid levels in men. J Clin Endocrinol Metab (2004) 1.36
Incidental movement, lifestyle-embedded activity and sleep: new frontiers in physical activity assessment. Can J Public Health (2007) 1.36
The human obesity gene map: the 2001 update. Obes Res (2002) 1.32
Plasma free fatty acid levels and the risk of ischemic heart disease in men: prospective results from the Québec Cardiovascular Study. Atherosclerosis (2002) 1.30
What is a normal glucose value? Differences in indexes of plasma glucose homeostasis in subjects with normal fasting glucose. Diabetes Care (2004) 1.29
Visceral adipose tissue accumulation, cardiorespiratory fitness, and features of the metabolic syndrome. Arch Intern Med (2007) 1.26
Postprandial variations of plasma inflammatory markers in abdominally obese men. Obesity (Silver Spring) (2006) 1.25
Association between insulin secretion, insulin sensitivity and type 2 diabetes susceptibility variants identified in genome-wide association studies. Acta Diabetol (2008) 1.25
Acute effects of knowledge-based work on feeding behavior and energy intake. Physiol Behav (2006) 1.21
Appetite sensations and satiety quotient: predictors of energy intake and weight loss. Appetite (2006) 1.20
Long-chain omega-3 fatty acids regulate bovine whole-body protein metabolism by promoting muscle insulin signalling to the Akt-mTOR-S6K1 pathway and insulin sensitivity. J Physiol (2006) 1.20
Depot-specific modulation of rat intraabdominal adipose tissue lipid metabolism by pharmacological inhibition of 11beta-hydroxysteroid dehydrogenase type 1. Endocrinology (2007) 1.19
Risk factors for adult overweight and obesity in the Quebec Family Study: have we been barking up the wrong tree? Obesity (Silver Spring) (2009) 1.18
Associations of sedentary behavior, sedentary bouts and breaks in sedentary time with cardiometabolic risk in children with a family history of obesity. PLoS One (2013) 1.16
Effects of encapsulated green tea and Guarana extracts containing a mixture of epigallocatechin-3-gallate and caffeine on 24 h energy expenditure and fat oxidation in men. Br J Nutr (2005) 1.16
Modifications in food-group consumption are related to long-term body-weight changes. Am J Clin Nutr (2004) 1.16
Visceral and not subcutaneous abdominal adiposity reduction drives the benefits of a 1-year lifestyle modification program. Obesity (Silver Spring) (2012) 1.14
Inducible nitric oxide synthase induction underlies lipid-induced hepatic insulin resistance in mice: potential role of tyrosine nitration of insulin signaling proteins. Diabetes (2010) 1.14
The association between short sleep duration and weight gain is dependent on disinhibited eating behavior in adults. Sleep (2011) 1.14
Awakening cortisol response in lean, obese, and reduced obese individuals: effect of gender and fat distribution. Obesity (Silver Spring) (2007) 1.13
Increased fat accumulation in liver may link insulin resistance with subcutaneous abdominal adipocyte enlargement, visceral adiposity, and hypoadiponectinemia in obese individuals. Am J Clin Nutr (2008) 1.12
Physical activity plays an important role in body weight regulation. J Obes (2010) 1.12
Effects of experimental weight perturbation on skeletal muscle work efficiency, fuel utilization, and biochemistry in human subjects. Am J Physiol Regul Integr Comp Physiol (2009) 1.12
Age-related differences in inflammatory markers in men: contribution of visceral adiposity. Metabolism (2009) 1.11
Appetite sensations as a marker of overall intake. Br J Nutr (2005) 1.11
Prevalence of 'hypertriglyceridemic waist' in men who participated in the Quebec Health Survey: association with atherogenic and diabetogenic metabolic risk factors. Can J Cardiol (2002) 1.11
Short sleep duration is independently associated with overweight and obesity in Quebec children. Can J Public Health (2011) 1.08
The human obesity gene map: the 2002 update. Obes Res (2003) 1.08
Associations between weight loss-induced changes in plasma organochlorine concentrations, serum T(3) concentration, and resting metabolic rate. Toxicol Sci (2002) 1.08
Dairy food and body fat: when the epidemiologist meets the physiologist. Am J Clin Nutr (2013) 1.07
Targeted disruption of carcinoembryonic antigen-related cell adhesion molecule 1 promotes diet-induced hepatic steatosis and insulin resistance. Endocrinology (2009) 1.06
Inverse relationship between exercise economy and oxidative capacity in muscle. Eur J Appl Physiol (2005) 1.06
Dietary cod protein improves insulin sensitivity in insulin-resistant men and women: a randomized controlled trial. Diabetes Care (2007) 1.05
Relation between appetite ratings before and after a standard meal and estimates of daily energy intake in obese and reduced obese individuals. Appetite (2003) 1.05
Metabolic effects of spices, teas, and caffeine. Physiol Behav (2006) 1.05
Management of antipsychotic-induced weight gain: prospective naturalistic study of the effectiveness of a supervised exercise programme. Aust N Z J Psychiatry (2007) 1.04
Contribution of age and declining androgen levels to features of the metabolic syndrome in men. Metabolism (2005) 1.04
Sex differences in postprandial plasma tumor necrosis factor-alpha, interleukin-6, and C-reactive protein concentrations. Metabolism (2009) 1.04
Combined associations between moderate to vigorous physical activity and sedentary behaviour with cardiometabolic risk factors in children. Appl Physiol Nutr Metab (2013) 1.03
A novel interaction between dietary composition and insulin secretion: effects on weight gain in the Quebec Family Study. Am J Clin Nutr (2008) 1.03
Glycemic instability and spontaneous energy intake: association with knowledge-based work. Psychosom Med (2008) 1.02
Greater than predicted decrease in energy expenditure during exercise after body weight loss in obese men. Clin Sci (Lond) (2003) 1.02
Ability of different adiposity indicators to identify children with elevated blood pressure. J Hypertens (2011) 1.01
Neuromedin beta: a strong candidate gene linking eating behaviors and susceptibility to obesity. Am J Clin Nutr (2004) 1.01
Increased plasma levels of toxic pollutants accompanying weight loss induced by hypocaloric diet or by bariatric surgery. Obes Surg (2006) 1.01
The alpha-subunit of AMPK is essential for submaximal contraction-mediated glucose transport in skeletal muscle in vitro. Am J Physiol Endocrinol Metab (2008) 1.00
Psychobiological impact of a progressive weight loss program in obese men. Physiol Behav (2005) 1.00
Sleep apnoea attenuates the effects of a lifestyle intervention programme in men with visceral obesity. Thorax (2012) 1.00
Contributions of cardiorespiratory fitness and visceral adiposity to six-year changes in cardiometabolic risk markers in apparently healthy men and women. J Clin Endocrinol Metab (2011) 1.00
Glucose homeostasis predicts weight gain: prospective and clinical evidence. Diabetes Metab Res Rev (2008) 0.99
Endotoxin mediated-iNOS induction causes insulin resistance via ONOO⁻ induced tyrosine nitration of IRS-1 in skeletal muscle. PLoS One (2010) 0.99
Prevention of gestational diabetes mellitus: a review of studies on weight management. Diabetes Metab Res Rev (2010) 0.99